| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/23/2002 | CN1332251A Production process of infections chicken cloacal bursa virus resisting monoclonal antibody |
| 01/23/2002 | CN1331914A Breeding method of black leg-resisting tobacco variety 'Honghuadajinyuan' |
| 01/23/2002 | CN1078250C Reshaped monoclonal antibodies against immunoglobulin isotype |
| 01/23/2002 | CN1078248C Insulin-secreting cell lines, methods of production and use |
| 01/23/2002 | CN1078042C Method for production of proteins in plant fluids |
| 01/22/2002 | US6340981 Method and apparatus for stroke substitution |
| 01/22/2002 | US6340740 An isolated polypeptide involved in modulating apoptotis; therapy for acquired immunodeficiency syndrome (aids), nervous system disorders and ischemic injury |
| 01/22/2002 | US6340668 Administering bone morphogenetic protein-11 (bmp-11) to neuronal cells effective to promote the survival of cells |
| 01/22/2002 | US6340595 A library of unique expressible nucleic acids within a multiplicity of compartments consisting of adenoviral vectors that are introduced into replication defective host cells; for determining functions of nucleic acid sequences |
| 01/22/2002 | US6340593 Plant-optimized polynucleotides encoding approximately 15 kDa and approximately 45 kDa pesticidal proteins |
| 01/22/2002 | US6340592 Human cell lines |
| 01/22/2002 | US6340578 High speed determination of three-dimensional structure using isotopes; polypeptide biosynthesis |
| 01/22/2002 | US6340577 Protein fragments for use in protein targeting |
| 01/22/2002 | US6340575 An isolated nucleic acid encoding a ras superfamily, rac gene, that modulates gtpase activity; cancer therapy |
| 01/22/2002 | US6340574 Regulated autocrine growth of mammalian cells |
| 01/22/2002 | US6340571 Antibodies specific for Staphylococcus aureus, and use thereof |
| 01/22/2002 | US6340569 Monoclonal antibody and antigens specific therefor and methods of using same |
| 01/22/2002 | US6340459 Administering to agent capable of inhibiting interaction between cd40 ligand and the cells to inhibit activation of the cells in therapy of reperfusion injury, in an non-transplant recipient |
| 01/22/2002 | CA2038398C Dna encoding a growth factor specific for epithelial cells |
| 01/17/2002 | WO2002004665A2 Method with a wide range of applications, for identifying modulators of g-protein-coupled receptors |
| 01/17/2002 | WO2002004654A2 Method for determining an<i> in vitro</i> cell model imitating the expression profile of a gene of interest in an <i>in vivo</i> cell |
| 01/17/2002 | WO2002004647A1 Dna sequences coding for a polyol carrier and use thereof, in particular for preparing transgenic plants |
| 01/17/2002 | WO2002004646A1 Expression system |
| 01/17/2002 | WO2002004623A2 ANTISENSE COMPOSITIONS TARGETED TO β1 ADRENOCEPTOR-SPECIFIC MRNA AND METHODS OF USE |
| 01/17/2002 | WO2002004619A2 Dehydroquinate dehydrase/shikimate dehydrogenase as a herbicide target |
| 01/17/2002 | WO2002004618A1 Methods of producing and using a human microglial cell line |
| 01/17/2002 | WO2002004612A2 Drug metabolizing enzymes |
| 01/17/2002 | WO2002004611A2 Aminoacyl trna synthetases |
| 01/17/2002 | WO2002004609A2 Mutations of cryptic splice sites in cre and cre fused proteins for improvement of expression and inducibility |
| 01/17/2002 | WO2002004607A1 Human myeloma cell line |
| 01/17/2002 | WO2002004606A1 Use of bioactive glass compositions to stimulate osteoblast production |
| 01/17/2002 | WO2002004605A2 Stimulation of cellular regeneration and differentiation in the inner ear |
| 01/17/2002 | WO2002004604A2 Immortalized human microglia cell and continuous cell line |
| 01/17/2002 | WO2002004600A2 Novel compounds |
| 01/17/2002 | WO2002004599A2 Placental protein having multiple egf-like domains |
| 01/17/2002 | WO2002004598A2 Improvement of cell culture performance by inhibitors of pyruvate dehydrogenase kinase |
| 01/17/2002 | WO2002004595A2 Production of chimeric human papillomavirus |
| 01/17/2002 | WO2002004523A2 Artificial antibody polypeptides |
| 01/17/2002 | WO2002004520A2 Transporters and ion channels |
| 01/17/2002 | WO2002004516A2 Use of the heat shock protein gp96 |
| 01/17/2002 | WO2002004514A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/17/2002 | WO2002004513A2 Down syndrome critical region 1-like 1 proteins |
| 01/17/2002 | WO2002004511A2 CHROMOSOME 3p21.3 GENES ARE TUMOR SUPPRESSORS |
| 01/17/2002 | WO2002004509A2 Gene expression, genome alteration and reporter expression in myofibroblasts and myofibroblast-like cells |
| 01/17/2002 | WO2002004496A2 Fimh adhesin proteins and methods of use |
| 01/17/2002 | WO2002004495A2 Streptococcus pyogenes antigen |
| 01/17/2002 | WO2002004493A2 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 01/17/2002 | WO2002004490A2 Lipid metabolism molecules |
| 01/17/2002 | WO2002004489A2 Polymorphic kinase anchor proteins and nucleic acids encoding the same |
| 01/17/2002 | WO2002004479A1 TRANSFORMING GROWTH FACTOR BETA (TGF-β) BLOCKING AGENT-TREATED STEM CELL COMPOSITION AND METHOD |
| 01/17/2002 | WO2002004022A1 High fidelity polymerases and uses thereof |
| 01/17/2002 | WO2002004010A2 Inhibition of tumor growth by a nematode anticoagulant protein |
| 01/17/2002 | WO2002004001A2 A composition for the delivery of live cells and methods of use |
| 01/17/2002 | WO2002003911A2 Prevention and treatment of alzheimer's disease |
| 01/17/2002 | WO2001072962A3 Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 01/17/2002 | WO2001061006A3 Two pore potassium channels, nucleotide sequences encoding them, and methods of using same |
| 01/17/2002 | WO2001059062A3 Method for obtaining in vitro polarized hepatoma cell lines |
| 01/17/2002 | WO2001052791A3 Complexes of peptide-binding fragments of heat shock proteins and their use as immunotherapeutic agents |
| 01/17/2002 | WO2001051922A3 Identification of peripheral benzodiazepine receptor binding agents |
| 01/17/2002 | WO2001049838A3 Cis-acting regulatory nucleic acid sequences in the parathyroid hormone 3'-untranslated region |
| 01/17/2002 | WO2001049106A3 Method for cloning animals with targetted genetic alterations |
| 01/17/2002 | WO2001047950A3 Basolateral sorting signal based on scf peptide and inhibitors thereof |
| 01/17/2002 | WO2001044448A3 Human oxidoreductase proteins |
| 01/17/2002 | WO2001044291A3 Polynucleotid encoding the rg1 polypeptide |
| 01/17/2002 | WO2001042211A3 Detection of transmembrane potentials by optical methods |
| 01/17/2002 | WO2001040446A3 Pour-on formulations |
| 01/17/2002 | WO2001036619A3 Cloning and characterization of the cap gene promoter |
| 01/17/2002 | WO2001036461A3 Compositions and methods for regulating tumor-associated antigen expression |
| 01/17/2002 | WO2001034833A3 Regulating endogenous inhibitor at atp synthase |
| 01/17/2002 | WO2001034820A3 Chemical inducible promoters used to obtain transgenic plants with a silent marker |
| 01/17/2002 | WO2001034769A3 24 human secreted proteins |
| 01/17/2002 | WO2001034091A3 Modification of polysaccharide containing materials |
| 01/17/2002 | WO2001032876A3 Compositions and methods for determining interactions of mitochondrial components, and for identifying agents that alter such interactions |
| 01/17/2002 | WO2001032838A3 Methods for improving viral vector titers and reducing cell death in cell cultures |
| 01/17/2002 | WO2001032696A3 Traf family proteins |
| 01/17/2002 | WO2001029192A3 Use of allogeneic cell lines to load antigen-presenting cells to elicit or eliminate immune responses |
| 01/17/2002 | WO2001027290A3 Aortic carboxypeptidase-like protein and nucleic acids encoding same |
| 01/17/2002 | WO2001022972A3 Immunostimulatory nucleic acids |
| 01/17/2002 | WO2001017687A3 Methods of modification of selected cells in a magnetic cell separation column |
| 01/17/2002 | WO2001016308A3 Plant sterol acyltransferases |
| 01/17/2002 | WO2001016293A3 Dna encoding the human serine protease t |
| 01/17/2002 | WO2001013117A3 Proteins, genes and their use for diagnosis and treatment of breast cancer |
| 01/17/2002 | WO2001012598A3 METHODS OF INHIBITING BINDING OF β-SHEET FIBRIL TO RAGE AND CONSEQUENCES THEREOF |
| 01/17/2002 | WO2001007471A3 Cell cycle and proliferation proteins |
| 01/17/2002 | WO2000078971A3 Atp binding cassette transporter protein abc1 popypeptides |
| 01/17/2002 | WO2000078953A3 Human transport proteins |
| 01/17/2002 | WO2000078952A3 Human rna metabolism proteins (rmep) |
| 01/17/2002 | WO2000063391A3 Nucleic acid sequences to proteins involved in tocopherol synthesis |
| 01/17/2002 | WO2000060077A3 Compounds for therapy and diagnosis of lung cancer and methods for their use |
| 01/17/2002 | US20020007498 P2x7 receptor-deficient non-human animals and uses thereof |
| 01/17/2002 | US20020007052 Point mutations; genetic engineering; hybridization |
| 01/17/2002 | US20020007051 Producing population of hybrid nucleic acid molecules via mixing populations of nucleic acid molecules containing multiple recombination sites; genetic engineering; gene expression |
| 01/17/2002 | US20020007046 Polypeptides for use in the diagnosis, prevention and treatment of cancer and immunological defects |
| 01/17/2002 | US20020006664 Arrayed transfection method and uses related thereto |
| 01/17/2002 | US20020006663 p27 and p21 in gene therapies |
| 01/17/2002 | US20020006662 Preferential aggregation; for use in the treatment of melanomas |
| 01/17/2002 | US20020006660 Genetically-modified neural progenitors and uses thereof |
| 01/17/2002 | US20020006657 Nucleic acids which encode insect acetylcholine receptor subunits |
| 01/17/2002 | US20020006649 Matrix; for use in wound healing |
| 01/17/2002 | US20020006640 Uteroglobin-like polynucleotides, polypeptides, and antibodies |